
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol. , 17 December 2020
Sec. Cancer Immunity and Immunotherapy
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.570128
This article is part of the Research Topic Genetic and Epigenetic Control on Immune Responses Regulating Molecules in Cancer Development, Progression, and Treatment View all 23 articles
A retraction of this article was approved in:
Retraction: Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer
Citation: Lin S, Liu Q, Wen J, Bai K, Guo Y and Wang J (2020) Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer. Front. Oncol. 10:570128. doi: 10.3389/fonc.2020.570128
Received: 06 June 2020; Accepted: 09 November 2020;
Published: 17 December 2020; Retracted: 17 October 2024.
Edited by:
Lidia Karabon, Polish Academy of Sciences, PolandReviewed by:
Ying Ma, University of Texas MD Anderson Cancer Center, United StatesDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.